Search
for
Sort by
Research 271–300 of 525
- IL-15 in alopecia areata: the immune tolerance mechanistic insights and translational perspectives
- Lichen Planopilaris Responsive to a Novel Phytoactive Botanical Treatment: A Case Series
- Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases
- PROTACs: A novel strategy for cancer drug discovery and development
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Advances in the treatment of autosomal recessive congenital ichthyosis, a look towards the repositioning of drugs
- An Updated in the Management of Alopecia Areata
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Granzyme B in Autoimmune Skin Disease
- Consensus on the treatment of alopecia areata – Brazilian Society of Dermatology
- Immunomodulatory Potential and Biocompatibility of Chitosan–Hydroxyapatite Biocomposites for Tissue Engineering
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Evaluation of the efficacy and treatment-emergent adverse events of deuruxolitinib for moderate to severe alopecia areata: a dose-ranging meta-analysis of 1,372 randomized patients
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Pathophysiology, conventional treatments, and evidence-based herbal remedies of hair loss with a systematic review of controlled clinical trials
- Iron Chelators in the Management of Autoimmune-Induced Alopecia: A Focus on Hypoxia-Inducible Factor 1 Modulation and Hair Restoration
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Challenges, Progress, and Prospects of Developing Therapies to Treat Autoimmune Diseases
- Alopecia Areata: Current Treatments and New Directions
- Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features
- How Our Microbiome Influences the Pathogenesis of Alopecia Areata
- Biomedical Technologies for Androgenic Alopecia Treatment: Advance, Mechanism and Future Direction
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Evaluation of Olive Oil-Based Formulations Loaded with Baricitinib for Topical Treatment of Alopecia Areata
- Kyoh® Rocket Leaf Extract Regulates Proliferation and VEGF and FGF7 Expression in Human Dermal Follicle Papilla Cells